Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Clin Infect Dis ; 76(3): e1021-e1030, 2023 02 08.
Artículo en Inglés | MEDLINE | ID: mdl-36048543

RESUMEN

BACKGROUND: Antibiotics are prescribed to most pediatric intensive care unit (PICU) patients, but data describing indications and appropriateness of antibiotic orders in this population are lacking. METHODS: We performed a multicenter point prevalence study that included children admitted to 10 geographically diverse PICUs over 4 study days in 2019. Antibiotic orders were reviewed for indication, and appropriateness was assessed using a standardized rubric. RESULTS: Of 1462 patients admitted to participating PICUs, 843 (58%) had at least 1 antibiotic order. A total of 1277 antibiotic orders were reviewed. Common indications were empiric therapy for suspected bacterial infections without sepsis or septic shock (260 orders, 21%), nonoperative prophylaxis (164 orders, 13%), empiric therapy for sepsis or septic shock (155 orders, 12%), community-acquired pneumonia (CAP; 118 orders, 9%), and post-operative prophylaxis (94 orders, 8%). Appropriateness was assessed for 985 orders for which an evidence-based rubric for appropriateness could be created. Of these, 331 (34%) were classified as inappropriate. Indications with the most orders classified as inappropriate were empiric therapy for suspected bacterial infection without sepsis or septic shock (78 orders, 24%), sepsis or septic shock (55 orders, 17%), CAP (51 orders, 15%), ventilator-associated infections (47 orders, 14%), and post-operative prophylaxis (44 orders, 14%). The proportion of antibiotics classified as inappropriate varied across institutions (range, 19%-43%). CONCLUSIONS: Most PICU patients receive antibiotics. Based on our study, we estimate that one-third of antibiotic orders are inappropriate. Improved antibiotic stewardship and research focused on strategies to optimize antibiotic use in critically ill children are needed.


Asunto(s)
Infecciones Bacterianas , Sepsis , Choque Séptico , Niño , Humanos , Antibacterianos/uso terapéutico , Choque Séptico/tratamiento farmacológico , Prevalencia , Unidades de Cuidado Intensivo Pediátrico , Sepsis/tratamiento farmacológico , Sepsis/epidemiología , Infecciones Bacterianas/tratamiento farmacológico
2.
J Pediatr Intensive Care ; 11(3): 254-258, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35928035

RESUMEN

Optimal practices for the placement of central venous catheters (CVCs) in critically ill children are unclear. This study describes the clinical practice of pediatric critical care medicine (PCCM) providers regarding CVC placement, including site selection, confirmation practices and assessment of complications. Two-hundred fourteen PCCM providers responded to an electronic survey, including 170 (79%) attending physicians, 30 (14%) fellow physicians, and 14 (7%) advanced practice providers. PCCM providers most commonly place internal jugular (IJ) and femoral CVCs, with subclavian CVCs and peripherally inserted central catheters (PICCs) placed less commonly (IJ 99%, femoral 95%, subclavian 40%, PICC 19%). The IJ is the most preferred site (128/214 (60%)); decreased infection risk is the most common reason for preferring this site. The subclavian is the least preferred site (150/214 [70%]) due to concern for increased risk of complications (51%) and personal discomfort with the procedure (49%). One-hundred twenty-six (59%) of respondents reported receiving formal ultrasound (US) or echocardiography training. Respondents reported using dynamic US guidance for placement in 90% of IJ, 86% of PICC, 78% of femoral, and 12% of subclavian CVCs. Plain radiography (X-ray) was the most preferred modality for confirming CVC tip position (85%) compared with US (9%) and no imaging (5%). Most providers reported using X-ray to evaluate for pneumothorax following upper extremity CVC placement, with only 5% reporting use of US and none relying on physical exam alone. This study demonstrates wide variability in PCCM providers' CVC placement practices. Potential training gaps exist for placement of subclavian catheters and use of US.

3.
Int J Dev Neurosci ; 82(7): 569-575, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-35916062

RESUMEN

BACKGROUND: Attention Deficit Hyperactivity Disorder (ADHD) is among the most prevalent childhood disorders. This condition is characterized by impulsive behaviour, restlessness and lack of concentration. Various researchers have come up with diverse conclusions concerning the risk factors of ADHD. OBJECTIVE: However, there is a need for a comprehensive review to understand the risk factors associated with the development of ADHD. METHODS: For this, Preferred Reporting Items for Systematic Reviews (PRISMA), the methodology was used to extract the findings. RESULTS: The finding suggests that there are a variety of risk factors associated with women that may be responsible for the development of ADHD among children. The main four risk factors are antibiotics use in early life, insufficient omega 3 and 6 in the body, disruption of gut microbiota and irregular circadian rhythm. These factors, which are discussed in-depth in the review, include factors that affect the development of the brain in children. CONCLUSION: This review concludes that a variety of risk factors may contribute to the development of ADHD. Further, this review highlights not only the importance of metabolic physiological but also the importance of biopsychological aspects that leads to the development of ADHD among children. Studies should be conducted to check the impact of such factors holistically to minimize the risk of ADHD.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad , Ácidos Grasos Omega-3 , Niño , Humanos , Femenino , Encéfalo , Ritmo Circadiano , Factores de Riesgo
4.
J Pediatr Intensive Care ; 11(1): 13-18, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-35178273

RESUMEN

Viral respiratory infections are a leading cause of illness and hospitalization in young children worldwide. Case fatality rates in pediatric patients with adenoviral lower respiratory tract infection requiring intensive care unit (ICU) admission have been reported between 7 and 22%. We investigated the demographics and clinical characteristics in pediatric mortalities associated with adenoviral respiratory infection at 12 academic children's hospitals in the United States. There were 107 mortality cases included in our study, 73% of which had a chronic medical condition. The most common chronic medical condition was immunocompromised state in 37 cases (35%). The incidences of pediatric acute respiratory distress syndrome (78%) and multiple organ dysfunction syndrome (94%) were profound. Immunocompetent cases were more likely to receive mechanical ventilation within the first hour of ICU admission (60 vs. 14%, p < 0.001) and extracorporeal membrane oxygenation (27 vs. 5%, p = 0.009), and less likely to receive continuous renal replacement therapy (20 vs. 49%, p = 0.002) or have renal dysfunction (54 vs. 78%, p = 0.014) as compared with immunocompromised cases. Immunocompromised cases were more likely to have bacteremia (57 vs. 16%, p < 0.001) and adenoviremia (51 vs. 17%, p < 0.001) and be treated with antiviral medications (81 vs. 26%, p < 0.001). We observed a high burden of nonrespiratory organ system dysfunction in a cohort of pediatric case fatalities with adenoviral respiratory infection. The majority of cases had a chronic medical condition associated with an increased risk of complications from viral respiratory illness, most notably immunocompromised state. Important treatment differences were noted between immunocompromised and immunocompetent cases.

5.
Front Pediatr ; 9: 681055, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34277520

RESUMEN

We describe the case of a newborn who presented with multiple organ dysfunction syndrome (MODS) and hyperferritinemia, who eventually met criteria for hemophagocytic lymphohistiocytosis (HLH) due to disseminated herpes simplex virus 1 (HSV-1). While the cytokine storm abated after administration of multiple immune modulatory therapies including dexamethasone, etoposide, intravenous immune globulin, anakinra, as well as the interferon gamma antagonist emapalumab, multiple organ dysfunction syndrome progressed. Care was withdrawn after 5 days. Subsequent genetic testing did not reveal any mutations associated with familial HLH. This case highlights that even with appropriate antiviral treatment and immune suppression, disseminated HSV is often fatal. Further study is warranted to determine whether early immune modulatory therapy including interferon gamma blockade can interrupt the HLH inflammatory cascade and prevent progression of MODS.

6.
Pediatr Infect Dis J ; 40(4): e154-e156, 2021 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-33427801

RESUMEN

ABSTRACT: Mycoplasma pneumoniae (MP) is an atypical bacterial pathogen that typically causes mild respiratory symptoms. Rarely, MP is associated with acute respiratory distress syndrome, a condition marked by widespread inflammation in the lungs that often requires invasive support. We report a case of severe acute respiratory distress syndrome requiring veno-venous extracorporeal membrane oxygenation in an otherwise healthy adolescent because of MP.


Asunto(s)
Oxigenación por Membrana Extracorpórea/métodos , Mycoplasma pneumoniae/efectos de los fármacos , Neumonía por Mycoplasma/terapia , Síndrome de Dificultad Respiratoria/microbiología , Síndrome de Dificultad Respiratoria/terapia , Antibacterianos/uso terapéutico , Niño , Voluntarios Sanos , Humanos , Masculino , Mycoplasma pneumoniae/genética , Mycoplasma pneumoniae/patogenicidad , Neumonía por Mycoplasma/diagnóstico por imagen , Neumonía por Mycoplasma/tratamiento farmacológico , Síndrome de Dificultad Respiratoria/diagnóstico por imagen , Síndrome de Dificultad Respiratoria/tratamiento farmacológico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA